Published in West J Med on February 01, 1992
Paradoxical worsening of tics with haloperidol. Ther Adv Psychopharmacol (2015) 0.75
Dr diaz, mr smith, and dr maccario respond. West J Med (1992) 0.75
Tic or dystonia? West J Med (1992) 0.75
The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. N Engl J Med (1986) 2.30
Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry (1986) 1.83
Gilles de la Tourette's syndrome: summary of clinical experience with 250 patients and suggested nomenclature for tic syndromes. Adv Neurol (1976) 1.20
The effect of central nervous system stimulants on Tourette syndrome. Ann Neurol (1977) 1.10
The phenomenology of tics. Mov Disord (1986) 1.04
Familial Tourette's syndrome in a large British pedigree. Associated psychopathology, severity, and potential for linkage analysis. Br J Psychiatry (1990) 1.03
Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder. Am J Psychiatry (1988) 0.99
Gilles de la Tourette's syndrome: tics and central nervous system stimulants in twins and nontwins. Neurology (1986) 0.95
[A case of tic of Gilles de la Tourette cured by R 1625]. Ann Med Psychol (Paris) (1961) 0.95
A controlled family history study of Tourette's syndrome, I: Attention-deficit hyperactivity disorder and learning disorders. J Clin Psychiatry (1990) 0.94
Neuroleptic-induced tics in two hyperactive children. Am J Psychiatry (1986) 0.93
Genetic linkage is excluded for the D2-dopamine receptor lambda HD2G1 and flanking loci on chromosome 11q22-q23 in Tourette syndrome. Hum Hered (1990) 0.91
Worsening of Tourette's disorder due to neuroleptic-induced akathisia. Am J Psychiatry (1987) 0.90
Cocaine and Tourette's syndrome. Ann Neurol (1988) 0.88
Long latency between the onset of motor and vocal tics in Tourette's syndrome. Ann Neurol (1983) 0.87
Tourette syndrome: a follow-up study. J Clin Psychopharmacol (1990) 0.86
Tics and heredity. A study of the relatives of child tiqueurs. Br J Psychiatry (1987) 0.82
Tourette-like syndrome after long-term neuroleptic drug treatment. Br J Psychiatry (1982) 0.82
Carbamazepine-induced tics. Dev Med Child Neurol (1984) 0.82
Tourette-like syndrome following low dose short-term neuroleptic treatment. Can J Neurol Sci (1986) 0.81
A case of oral dyskinesia associated with imipramine treatment. Am J Psychiatry (1977) 0.80
A case of Tourette syndrome developing during haloperidol treatment. Can J Psychiatry (1990) 0.80
Tic disorders of childhood. Am Fam Physician (1988) 0.80
Lingual nerve damage during lower third molar removal: a comparison of two surgical methods. Br Dent J (1996) 5.38
A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J (1998) 2.82
Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature (1995) 2.65
Lithium deintercalation in LiFePO4 nanoparticles via a domino-cascade model. Nat Mater (2008) 2.15
Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol (2003) 1.64
A study on the efficacy of late lingual nerve repair. Br J Oral Maxillofac Surg (1996) 1.58
Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr Biol (2000) 1.56
Dissecting affinity maturation: a model explaining selection of antibody-forming cells and memory B cells in the germinal centre. Immunol Today (2000) 1.49
T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors. Eur J Immunol (1986) 1.49
"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int (1996) 1.49
Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine (2013) 1.48
Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity. J Endocrinol Invest (1994) 1.42
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab (2001) 1.32
Neurological dysfunction associated with nonketotic hyperglycemia. Arch Neurol (1968) 1.26
Cerebral oedema complicating treated non-ketotic hyperglycaemia. Lancet (1969) 1.21
Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation (2000) 1.19
Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation (1999) 1.10
Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis (1999) 1.07
Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf) (2005) 1.04
Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int (2001) 1.03
Nerve damage and third molar removal. Dent Update (2003) 1.02
Superior sagittal sinus thrombosis and pulmonary embolism: a syndrome rediscovered. Acta Neurol Scand (1992) 1.01
Activation of epileptogenic foci by hyperosmolality. Neurology (1967) 1.00
Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. J Clin Endocrinol Metab (2000) 0.97
A prospective, quantitative study on the clinical outcome of lingual nerve repair. Br J Oral Maxillofac Surg (2000) 0.94
Soluble antigen can impede affinity maturation and the germinal center reaction but enhance extrafollicular immunoglobulin production. J Immunol (1995) 0.94
De novo partial duplications 1p: report of two new cases and review. Am J Med Genet (1999) 0.92
A case of lung myiasis caused by larvae of Megaselia spiracularis Schmitz (Diptera: Phoridae). Trans R Soc Trop Med Hyg (1978) 0.92
Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. Metabolism (1992) 0.91
Equipment and methods for simple sensory testing. Br J Oral Maxillofac Surg (1992) 0.91
Peritoneal dialysis in nondiabetic patients older than 70 years: comparison with patients aged 40 to 60 years. Am J Kidney Dis (1998) 0.91
Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. J Clin Endocrinol Metab (2003) 0.90
Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. Neuroendocrinology (1991) 0.90
Biologic activities of growth hormone secretagogues in humans. Endocrine (2001) 0.88
Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. J Clin Endocrinol Metab (2003) 0.88
Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol (Oxf) (2004) 0.88
Cuff-shaving procedure. A rescue treatment for exit-site infection unresponsive to medical therapy. Nephrol Dial Transplant (1995) 0.87
Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. J Clin Endocrinol Metab (2002) 0.87
Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update. J Endocrinol Invest (2010) 0.85
Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans. J Clin Endocrinol Metab (2000) 0.85
Recurrent Kikuchi's disease. Lancet (1992) 0.85
Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects. Int J Obes Relat Metab Disord (1997) 0.84
Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity. J Endocrinol Invest (1999) 0.83
Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design. J Hum Hypertens (2012) 0.83
Development, optimization and characterization of a full-thickness tissue engineered human oral mucosal model for biological assessment of dental biomaterials. J Mater Sci Mater Med (2007) 0.82
Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans. J Clin Endocrinol Metab (2001) 0.82
Growth of porcine kidneys in their native and xenograft environment. Xenotransplantation (2000) 0.82
Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans. Eur J Endocrinol (2000) 0.82
Ectopic neural activity from myelinated afferent fibres in the lingual nerve of the ferret following three types of injury. Brain Res (2000) 0.82
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Am J Physiol (1999) 0.82
Ageing, growth hormone and physical performance. J Endocrinol Invest (2003) 0.82
Augmentin-induced jaundice with a fatal outcome. Med J Aust (1992) 0.82
Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study. J Neurol Sci (2001) 0.81
The effects of lithium on electroencephalogram, behavior and serum electrolytes. J Nerv Ment Dis (1970) 0.81
In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion. J Clin Endocrinol Metab (1997) 0.81
Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. Eur J Endocrinol (2010) 0.81
Comparisons among old and new provocative tests of GH secretion in 178 normal adults. Eur J Endocrinol (2000) 0.81
Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients. Nihon Geka Gakkai Zasshi (2000) 0.81
Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels. J Endocrinol Invest (1999) 0.80
Development dysphasia and electroencephalographic abnormalities. Dev Med Child Neurol (1982) 0.80
Initial experience of mitral valve replacement with total preservation of both valve leaflets. Tex Heart Inst J (1994) 0.80
Persistent neck disease after chemoradiation for head and neck squamous cell carcinoma. J Laryngol Otol (2012) 0.80
Double recurrence of FSGS after two renal transplants with complete regression after plasmapheresis and ACE inhibitors. Transpl Int (2000) 0.80
Altered muscle energy metabolism in post-absorptive patients with chronic renal failure. Scand J Urol Nephrol (1997) 0.80
Surgical anatomy of the buccal nerve. Br J Oral Maxillofac Surg (1996) 0.80
T cell activation by anti-CD3 antibodies: function of Fc receptors on B cell blasts, but not resting B cells, and CD18 on the responding T cells. Eur J Immunol (1987) 0.80
Extracapillary glomerulonephritis and renal amyloidosis. Am J Kidney Dis (1996) 0.80
Treatment of membranous lupus nephritis. Am J Kidney Dis (1998) 0.80
A quantitative morphological comparison of cat lingual nerve repair using epineurial sutures or entubulation. J Dent Res (1996) 0.79
Glucagon is an ACTH secretagogue as effective as hCRH after intramuscolar administration while it is ineffective when given intravenously in normal subjects. Pituitary (2000) 0.79
Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans. Eur J Endocrinol (2000) 0.79
Apoptosis and the B cell response to antigen. Int Rev Immunol (1997) 0.79
Analysis of risk factors for surgical wound infections following vascular surgery. Am J Med (1991) 0.79
Prevalence and characteristics of metabolic syndrome in primary hyperparathyroidism. J Endocrinol Invest (2011) 0.78
Paradoxical caloric response in altered states of consciousness. Clinical and EEG correlations in toxic metabolic encephalopathies. Neurology (1972) 0.78
Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span. J Pediatr Endocrinol Metab (2000) 0.78
The entomology of the cadaver. Med Sci Law (1970) 0.77
Interactions of galanin and arginine on growth hormone, prolactin, and insulin secretion in man. Metabolism (1992) 0.77
Diagnosis of GH deficiency in adults. Growth Horm IGF Res (1998) 0.77
Sudden death in Moersch-Woltman. Neurology (1984) 0.77
Enhancement of the peripheral sensitivity to growth hormone in adults with GH deficiency. Eur J Endocrinol (2001) 0.77
Long-term results with cyclosporine monotherapy in renal transplant patients: a multivariate analysis of risk factors. Am J Kidney Dis (2000) 0.77
Meningoencephalitis due to Mima polymorpha. N Y State J Med (1972) 0.77
Effects of viral inhibitors of apoptosis in models of mammalian cell death. Behring Inst Mitt (1996) 0.77
Hepatitis C-associated glomerulonephritis--a novel therapeutic approach. Nephrol Dial Transplant (2001) 0.77
9B.01: CLINICAL SIGNIFICANCE OF CONTRALATERAL ADRENAL SUPPRESSION DURING ADRENAL VEIN SAMPLING IN PRIMARY ALDOSTERONISM. J Hypertens (2015) 0.76
Control and function of the GH-IGF-I axis in obesity. Eat Weight Disord (2001) 0.76
Neonatal radiologic casebook. Group B streptococcal infection/cerebral necrosis. J Perinatol (1987) 0.76
Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine. Clin Endocrinol (Oxf) (1995) 0.76
DHEA-S levels in hypopituitaric patients with severe GH deficiency are strongly reduced across lifespan. Comparison with IGF-I levels before and during rhGH replacement. J Endocrinol Invest (2000) 0.76
Phenyl isopropyl adenosine alters fetal electrocorticogram, breathing and heart rate. Dev Pharmacol Ther (1986) 0.76
Glucagon administration elicits blunted GH but exaggerated ACTH response in obesity. J Endocrinol Invest (2002) 0.76
A quantitative morphological study of the recovery of cat lingual nerves after transection or crushing. J Anat (1996) 0.76
Endocrine and metabolic alterations in obstructive sleep apnea syndrome. J Endocrinol Invest (2003) 0.76
The effect of surgical technique on lingual nerve damage during lower 3rd molar removal by dental students. Eur J Dent Educ (1999) 0.76
Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans. Clin Endocrinol (Oxf) (1994) 0.76
Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands: focus on reproductive system. Endocrine (2001) 0.75
Paraneoplastic cerebellar degeneration due to Hodgkin's disease. West J Med (1989) 0.75
How clinical research changed the habit of a lifetime. Br Dent J (1997) 0.75